Health
Longer gap in Pfizer-BioNTech COVID vaccines boosts antibody levels: Study – THE WEEK
What is very clear is that two doses are required to maximise protection
A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found.
The study, led by the University of Oxford, in collaboration with the Universities of Birmingham,…
Continue Reading
-
Noosa News24 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn
-
Noosa News14 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
Noosa News19 hours agoManjimup engineer turns previously wasted avocados into liquid gold
-
Noosa News13 hours agoPeter Dutton insists there’s enough water for his seven nuclear plants, contradicting shadow frontbencher